Cellectis (CLLS) EPS (Basic) Growth (3y) (2018 - 2026)
Cellectis (CLLS) EPS (Basic) Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 53.55% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 37.73% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.29% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -2.89% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 86.43% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Cellectis | 281.48 Mn | 95.81 Mn | - | 99.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 99.85% |
| Dec 31, 2025 | 99.84% |
| Sep 30, 2025 | 26.19% |
| Jun 30, 2025 | 17.17% |
| Mar 31, 2025 | 99.87% |
| Dec 31, 2024 | 28.41% |
| Sep 30, 2024 | 31.55% |
| Jun 30, 2024 | 29.14% |
| Mar 31, 2024 | 30.96% |
| Dec 31, 2023 | 8.45% |
| Sep 30, 2023 | 23.88% |
| Jun 30, 2023 | 33.97% |
| Mar 31, 2023 | -47.91% |
| Dec 31, 2022 | 12.43% |
| Sep 30, 2022 | -18.37% |
| Jun 30, 2022 | 19.16% |
| Mar 31, 2022 | -28.33% |
| Dec 31, 2021 | 0.49% |
| Sep 30, 2021 | -15.24% |
| Jun 30, 2021 | -72.23% |